CA2866222C - Chemical process for preparing spiroindolones and intermediates thereof - Google Patents

Chemical process for preparing spiroindolones and intermediates thereof Download PDF

Info

Publication number
CA2866222C
CA2866222C CA2866222A CA2866222A CA2866222C CA 2866222 C CA2866222 C CA 2866222C CA 2866222 A CA2866222 A CA 2866222A CA 2866222 A CA2866222 A CA 2866222A CA 2866222 C CA2866222 C CA 2866222C
Authority
CA
Canada
Prior art keywords
compound
formula
salt
hydrate
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2866222A
Other languages
English (en)
French (fr)
Other versions
CA2866222A1 (en
Inventor
Michael Crowe
Michael Foulkes
Giancarlo Francese
Dominique Grimler
Ernst Kuesters
Kurt Laumen
Yunzhong Li
Changxue LIN
Jovana Nazor
Thomas Ruch
Derek Smith
Shiwei Song
Shangjun TENG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CA2866222A1 publication Critical patent/CA2866222A1/en
Application granted granted Critical
Publication of CA2866222C publication Critical patent/CA2866222C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
CA2866222A 2012-03-23 2013-03-22 Chemical process for preparing spiroindolones and intermediates thereof Active CA2866222C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2012000359 2012-03-23
CNPCT/CN2012/000359 2012-03-23
PCT/EP2013/056170 WO2013139987A1 (en) 2012-03-23 2013-03-22 Chemical process for preparing spiroindolones and intermediates thereof

Publications (2)

Publication Number Publication Date
CA2866222A1 CA2866222A1 (en) 2013-09-26
CA2866222C true CA2866222C (en) 2022-01-11

Family

ID=48048006

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2866222A Active CA2866222C (en) 2012-03-23 2013-03-22 Chemical process for preparing spiroindolones and intermediates thereof

Country Status (21)

Country Link
US (1) US9598712B2 (enExample)
EP (2) EP3578557B1 (enExample)
JP (1) JP6117906B2 (enExample)
KR (1) KR102057590B1 (enExample)
CN (1) CN104185634B (enExample)
AP (1) AP2014007906A0 (enExample)
AU (1) AU2013237330C1 (enExample)
BR (1) BR112014022909B1 (enExample)
CA (1) CA2866222C (enExample)
CY (1) CY1122087T1 (enExample)
DK (1) DK2828256T5 (enExample)
ES (2) ES2962530T3 (enExample)
HR (1) HRP20191632T1 (enExample)
HU (1) HUE046421T2 (enExample)
LT (1) LT2828256T (enExample)
MX (1) MX354023B (enExample)
PL (1) PL2828256T3 (enExample)
PT (1) PT2828256T (enExample)
RU (1) RU2662815C2 (enExample)
SI (1) SI2828256T1 (enExample)
WO (1) WO2013139987A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI784255B (zh) 2014-12-18 2022-11-21 瑞士商赫孚孟拉羅股份公司 四氫-吡啶并[3,4-b]吲哚雌激素受體調節劑及其用途
JP2017024992A (ja) * 2015-07-15 2017-02-02 公益財団法人微生物化学研究会 化合物の製造方法
LT3810283T (lt) 2018-06-21 2023-08-25 F. Hoffmann-La Roche Ag 3-((1r,3r)-1-(2,6-difluor-4-((1-(3-fluorpropil)azetidin-3- il)amino) fenil)-3-metil-1,3,4,9-tetrahidro-2h-pirido[3,4-b]indol-2-il)- 2,2- difluorpropan-1-olio tartrato druskos kietosios formos, jų paruošimo procesas ir jų naudojimo būdai vėžiui gydyti
CN111041015B (zh) * 2019-12-31 2022-03-18 浙江工业大学 一种高温下制备(r)-(+)-n-乙酰基-1-甲基-3-苯丙胺的方法
US11788071B2 (en) 2020-04-10 2023-10-17 Codexis, Inc. Engineered transaminase polypeptides
CN116209754A (zh) * 2020-09-28 2023-06-02 科德克希思公司 用于合成手性胺的工程化生物催化剂及方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2947758A (en) * 1959-04-28 1960-08-02 Searle & Co 3-(omega-hydrazino) alkylindoles
GB974895A (en) * 1961-04-06 1964-11-11 Parke Davis & Co Process for the production of amine compounds
GB974893A (en) * 1961-04-06 1964-11-11 Parke Davis & Co Amine compounds and means of producing the same
US3183170A (en) * 1961-10-03 1965-05-11 Sanraku Ocean Kabushiki Kaisha Method of l-amino acid manufacture
BE795457A (fr) * 1972-02-16 1973-08-16 Clin Midy Amines indoliques, leur preparation et leur application en therapeutiques
US4073795A (en) * 1976-06-22 1978-02-14 Hoffmann-La Roche Inc. Synthesis of tryptophans
US4331818A (en) * 1980-03-19 1982-05-25 The Procter & Gamble Company Chiral phospine ligand
DE3307095A1 (de) * 1983-03-01 1984-09-06 Degussa Ag, 6000 Frankfurt Mikrobiologisch hergestellte l-phenylalanin-dehydrogenase, verfahren zu ihrer gewinnung und ihre verwendung
US4518692A (en) * 1983-09-01 1985-05-21 Genetics Institute, Inc. Production of L-amino acids by transamination
DE3482982D1 (de) * 1983-09-01 1990-09-20 Genetics Inst Herstellung von l-aminosaeuren durch transaminierung.
US4859591A (en) * 1984-07-05 1989-08-22 W. R. Grace & Co.-Conn. Transamination process for producing amino acids
US4826766A (en) * 1985-09-23 1989-05-02 Genetics Institute, Inc. Production of amino acids using coupled aminotransferases
US7629157B2 (en) 2003-08-11 2009-12-08 Codexis, Inc. Ketoreductase polypeptides and related polynucleotides
US7541091B2 (en) 2004-05-18 2009-06-02 M & G Usa Corporation Compartmentalized resin pellets for oxygen scavenging
JPWO2006038520A1 (ja) * 2004-10-05 2008-05-15 味の素株式会社 ヒドロキシイミノ酸からのアミノ酸誘導体製造方法
WO2008050207A1 (en) * 2006-10-25 2008-05-02 Pfizer Limited Heterocyclic compounds useful as anabolic agents for livestock animals
EP2132322A4 (en) 2007-03-02 2013-02-20 Richmond Chemical Corp METHOD FOR INCREASING YIELD AND IMPROVING PURIFICATION OF PRODUCTS FROM REACTIONS WITH TRANSAMINASE
EP2285808B1 (en) * 2008-04-29 2013-11-20 Novartis AG Spiro-indole derivatives for the treatment of parasitic diseases
AT507050B1 (de) * 2008-06-17 2010-06-15 Angewandte Biokatalyse Kompete Verfahren zur herstellung von aminen unter verwendung von omega-transaminasen
HUE036104T2 (hu) 2009-01-08 2018-06-28 Codexis Inc Transzamináz polipeptidek
JP5999565B2 (ja) * 2010-07-14 2016-09-28 ディーピーエックス ホールディングス ビー.ブイ. (r)−選択的アミノ化
WO2013142770A1 (en) * 2012-03-23 2013-09-26 Codexis, Inc. Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs

Also Published As

Publication number Publication date
CN104185634A (zh) 2014-12-03
ES2748460T3 (es) 2020-03-16
EP3578557A1 (en) 2019-12-11
SI2828256T1 (sl) 2019-11-29
PL2828256T3 (pl) 2019-12-31
AU2013237330C1 (en) 2016-08-25
AP2014007906A0 (en) 2014-08-31
DK2828256T5 (da) 2019-12-09
RU2662815C2 (ru) 2018-07-31
LT2828256T (lt) 2019-09-25
EP3578557B1 (en) 2023-09-20
KR20140137374A (ko) 2014-12-02
PT2828256T (pt) 2019-10-18
HUE046421T2 (hu) 2020-02-28
JP2015512381A (ja) 2015-04-27
EP2828256A1 (en) 2015-01-28
WO2013139987A1 (en) 2013-09-26
BR112014022909B1 (pt) 2021-11-03
DK2828256T3 (da) 2019-10-07
HK1202289A1 (en) 2015-09-25
BR112014022909A2 (pt) 2017-07-18
CN104185634B (zh) 2017-05-03
HRP20191632T1 (hr) 2019-12-13
CY1122087T1 (el) 2020-11-25
ES2962530T3 (es) 2024-03-19
AU2013237330A1 (en) 2014-09-25
MX354023B (es) 2018-02-08
US9598712B2 (en) 2017-03-21
EP2828256B1 (en) 2019-07-03
MX2014011489A (es) 2015-05-11
AU2013237330B2 (en) 2015-12-03
US20150045562A1 (en) 2015-02-12
JP6117906B2 (ja) 2017-04-19
KR102057590B1 (ko) 2019-12-19
RU2014142621A (ru) 2016-05-20
CA2866222A1 (en) 2013-09-26

Similar Documents

Publication Publication Date Title
US12305201B2 (en) Engineered biocatalysts and methods for synthesizing chiral amines
DK2828385T3 (en) BIOCATALIZATORS AND METHODS FOR SYNTHETIZING DERIVATIVES AND TRYPTAMIN AND TRYPTAMINE ANALOGS
CN103998461B (zh) 用于合成取代的内酰胺的生物催化剂和方法
AU2013237330C1 (en) Chemical process for preparing spiroindolones and intermediates thereof
CN105018440A (zh) 一种转氨酶及其在合成西他列汀中间体中的应用
JP2021531749A (ja) 操作されたフェニルアラニンアンモニアリアーゼポリペプチド
CA3193755A1 (en) Engineered biocatalysts and methods for synthesizing chiral amines
HK40013831A (en) Chemical process for preparing spiroindolones and intermediates thereof
HK40013831B (en) Chemical process for preparing spiroindolones and intermediates thereof
HK1202289B (en) Chemical process for preparing spiroindolones and intermediates thereof

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180222

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241220

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241220

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241220

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD

Year of fee payment: 13

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251216

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251216